Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry

October 2024 in “ bioRxiv (Cold Spring Harbor Laboratory) ”

Hannah C. Scott, Martin Philpott, G. Berridge, Zhanru Yu, Darragh P. O’Brien, Christian Becker, Cecilia Lindgren, Udo Opperman, Joerg Mueller, Martin Fritsch, Adán Pinto-Fernández, Benedikt M. Kessler

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on biorxiv.org →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Androgen Excess: Investigations and Management

82 citations , May 2016 in “Best Practice & Research in Clinical Obstetrics & Gynaecology”

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS)

4025 citations , December 2003 in “Human Reproduction”

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

research Prevalence of Polycystic Ovaries in Women with Androgenic Alopecia

84 citations , November 2003 in “European journal of endocrinology”

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

research Bioavailability of Albumin-Bound Testosterone

255 citations , October 1985 in “The Journal of Clinical Endocrinology & Metabolism”

Spironolactone treatment increases the amount of testosterone available in the body.